Worsened blood circulation from autonomic dysfunction may contribute to depressive symptoms, offering a new avenue for ...

An integrative Translational Psychiatry study linked BPA exposure to major depressive disorder by identifying 571 shared ...

A major depressive episode can evolve from seemingly minor "blues" with surprising speed, eventually disrupting your career, ...

A recent study published in the journal Molecular Psychiatry provides evidence that an individual’s genetic risk for major depression tends to be higher in those who develop more severe forms of the ...

A recent study published in Nature Medicine suggests that a brief psychedelic experience combined with talk therapy can ...

Spravato (esketamine) is a nasal spray used for depression and was approved by the FDA in 2019. It is specifically for treatment-resistant depression, meaning depression symptoms that have not gotten ...

BullFrog AI (BFRG) stock jumped 106% after announcing a drug discovery deal with a top-5 pharma firm targeting major ...

Older adults with major depressive disorder (MDD) exhibit riskier driving behaviors than their nondepressed peers, including hard braking, cornering, and unpredictable driving patterns, new research ...

The Icahn School of Medicine at Mount Sinai today announced the enrollment of its first patient in a U.S. Department of ...

In this study, researchers aimed to characterize the relationship between major depressive disorder, use of antidepressants, and risk of recurrence in breast cancer patients.